Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Protective Efficacy of a Spatial Repellent to Reduce Malaria Prevalence in Children ≤ 5 Years of Age in Uganda: Study Protocol for a Cluster-randomized Double-blinded Control Trial: The Mossie-GO Trial

NCT06232954 is registered in ClinicalTrials.gov with Africa Power Limited as lead sponsor.

NCT NCT06232954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06232954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Protective Efficacy of a Spatial Repellent to Reduce Malaria Prevalence in Children ≤ 5 Years of Age in Uganda: Study Protocol for a Cluster-randomized Double-blinded Control Trial: The Mossie-GO Trial
Lead sponsor
Africa Power Limited
Phase
Not applicable
Overall status
Unknown status
Start date
June 5, 2024
Completion date
September 30, 2025
Enrollment
5,600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, mosquito-borne disease